Skip to main content
Erschienen in: Die Anaesthesiologie 11/2020

07.10.2020 | Sepsis | Journal Club

Fokus allgemeine Intensivmedizin

Intensivmedizinische Studien aus 2019/2020

Erschienen in: Die Anaesthesiologie | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Auszug

Dieser Beitrag ist Teil einer Serie zu den wichtigsten intensivmedizinischen Studien aus 2019/2020. Alle Artikel stehen Ihnen auf www.​springermedizin.​de zur Verfügung. Bitte geben Sie dort den Beitragstitel (Fokus) in die Suche ein. Die Serie umfasst:
Literatur
1.
Zurück zum Zitat Mouncey PR et al (2015) Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372(14):1301–1311CrossRefPubMed Mouncey PR et al (2015) Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372(14):1301–1311CrossRefPubMed
2.
Zurück zum Zitat Investigators A et al (2014) Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371(16):1496–1506CrossRef Investigators A et al (2014) Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371(16):1496–1506CrossRef
3.
Zurück zum Zitat Pro CI et al (2014) A randomized trial of protocol-based care for early septic shock. N Engl J Med 370(18):1683–1693CrossRef Pro CI et al (2014) A randomized trial of protocol-based care for early septic shock. N Engl J Med 370(18):1683–1693CrossRef
4.
Zurück zum Zitat Rivers E et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368–1377CrossRefPubMed Rivers E et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368–1377CrossRefPubMed
5.
Zurück zum Zitat Rhodes A et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45(3):486–552CrossRefPubMed Rhodes A et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45(3):486–552CrossRefPubMed
6.
Zurück zum Zitat Brunkhorst FM, Pletz M, Gastmeier P, Lemmen SW, Meier-Hellmann A, Ragaller M, Weyland A, Marx G, Bucher M, Gerlach H, Salzberger B, Grabein B, Welte T, Werdan K, Kluge S, Bone HG, Putensen Ch, Rossaint R, Quintel M, Spies C, Weiß B, John S, Opp AH et al (2018) S3-Leitlinie Sepsis Prävention Diagnose Therapie und Nachsorge Brunkhorst FM, Pletz M, Gastmeier P, Lemmen SW, Meier-Hellmann A, Ragaller M, Weyland A, Marx G, Bucher M, Gerlach H, Salzberger B, Grabein B, Welte T, Werdan K, Kluge S, Bone HG, Putensen Ch, Rossaint R, Quintel M, Spies C, Weiß B, John S, Opp AH et al (2018) S3-Leitlinie Sepsis Prävention Diagnose Therapie und Nachsorge
7.
Zurück zum Zitat Levy MM, Evans LE, Rhodes A (2018) The surviving sepsis campaign bundle: 2018 update. Crit Care Med 46(6):997–1000CrossRefPubMed Levy MM, Evans LE, Rhodes A (2018) The surviving sepsis campaign bundle: 2018 update. Crit Care Med 46(6):997–1000CrossRefPubMed
8.
Zurück zum Zitat Kahn JM et al (2019) Association between state-mandated protocolized sepsis care and in-hospital mortality among adults with sepsis. JAMA 322(3):240–250CrossRefPubMedPubMedCentral Kahn JM et al (2019) Association between state-mandated protocolized sepsis care and in-hospital mortality among adults with sepsis. JAMA 322(3):240–250CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Brown RM et al (2019) Balanced crystalloids versus saline in sepsis. A secondary analysis of the SMART clinical trial. Am J Respir Crit Care Med 200(12):1487–1495CrossRefPubMedPubMedCentral Brown RM et al (2019) Balanced crystalloids versus saline in sepsis. A secondary analysis of the SMART clinical trial. Am J Respir Crit Care Med 200(12):1487–1495CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Frydland M et al (2015) Target temperature management of 33 degrees C and 36 degrees C in patients with out-of-hospital cardiac arrest with initial non-shockable rhythm—a TTM sub-study. Resuscitation 89:142–148CrossRefPubMed Frydland M et al (2015) Target temperature management of 33 degrees C and 36 degrees C in patients with out-of-hospital cardiac arrest with initial non-shockable rhythm—a TTM sub-study. Resuscitation 89:142–148CrossRefPubMed
12.
Zurück zum Zitat Nielsen N et al (2013) Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med 369(23):2197–2206CrossRefPubMed Nielsen N et al (2013) Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med 369(23):2197–2206CrossRefPubMed
13.
Zurück zum Zitat Bergamin FS et al (2017) Liberal versus restrictive transfusion strategy in critically ill oncologic patients: the transfusion requirements in critically ill oncologic patients randomized controlled trial. Crit Care Med 45(5):766–773CrossRefPubMed Bergamin FS et al (2017) Liberal versus restrictive transfusion strategy in critically ill oncologic patients: the transfusion requirements in critically ill oncologic patients randomized controlled trial. Crit Care Med 45(5):766–773CrossRefPubMed
14.
Zurück zum Zitat Holst LB et al (2014) Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371(15):1381–1391CrossRefPubMed Holst LB et al (2014) Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371(15):1381–1391CrossRefPubMed
15.
Zurück zum Zitat Hebert PC et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340(6):409–417CrossRefPubMed Hebert PC et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340(6):409–417CrossRefPubMed
16.
Zurück zum Zitat Marik PE et al (2017) Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest 151(6):1229–1238CrossRefPubMed Marik PE et al (2017) Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest 151(6):1229–1238CrossRefPubMed
18.
Zurück zum Zitat Carr AC et al (2017) Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care 21(1):300CrossRefPubMedPubMedCentral Carr AC et al (2017) Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care 21(1):300CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Fowler AA 3rd et al (2019) Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA 322(13):1261–1270CrossRefPubMedPubMedCentral Fowler AA 3rd et al (2019) Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA 322(13):1261–1270CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Fujii T et al (2020) Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial. JAMA 323(5):423–431CrossRefPubMedPubMedCentral Fujii T et al (2020) Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial. JAMA 323(5):423–431CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Amrein K et al (2014) Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA 312(15):1520–1530CrossRefPubMed Amrein K et al (2014) Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA 312(15):1520–1530CrossRefPubMed
23.
Zurück zum Zitat National Heart L et al (2019) Early high-dose vitamin D3 for critically ill, vitamin D‑deficient patients. N Engl J Med 381(26):2529–2540CrossRef National Heart L et al (2019) Early high-dose vitamin D3 for critically ill, vitamin D‑deficient patients. N Engl J Med 381(26):2529–2540CrossRef
24.
Zurück zum Zitat Lyons PG et al (2018) Sepsis-associated coagulopathy severity predicts hospital mortality. Crit Care Med 46(5):736–742CrossRefPubMed Lyons PG et al (2018) Sepsis-associated coagulopathy severity predicts hospital mortality. Crit Care Med 46(5):736–742CrossRefPubMed
25.
Zurück zum Zitat Vincent JL et al (2019) Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial. JAMA 321(20):1993–2002CrossRefPubMedPubMedCentral Vincent JL et al (2019) Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial. JAMA 321(20):1993–2002CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Fineberg, D., Scarlet-2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess The Safety And Efficacy of ART-123 in Subjects With Sepsis and Coagulopathy, C.g.I. NCT03517501, Editor Fineberg, D., Scarlet-2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess The Safety And Efficacy of ART-123 in Subjects With Sepsis and Coagulopathy, C.g.I. NCT03517501, Editor
27.
Zurück zum Zitat Tong SY et al (2015) Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28(3):603–661CrossRefPubMedPubMedCentral Tong SY et al (2015) Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28(3):603–661CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Liu C et al (2011) Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52(3):285–292CrossRefPubMed Liu C et al (2011) Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52(3):285–292CrossRefPubMed
29.
Zurück zum Zitat Tong SYC et al (2020) Effect of vancomycin or daptomycin with vs without an antistaphylococcal beta-Lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial. JAMA 323(6):527–537CrossRefPubMedPubMedCentral Tong SYC et al (2020) Effect of vancomycin or daptomycin with vs without an antistaphylococcal beta-Lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial. JAMA 323(6):527–537CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Kalil AC et al (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of america and the American thoracic society. Clin Infect Dis 63(5):e61–e111CrossRefPubMedPubMedCentral Kalil AC et al (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of america and the American thoracic society. Clin Infect Dis 63(5):e61–e111CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Kollef MH et al (2019) Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial. Lancet Infect Dis 19(12):1299–1311CrossRefPubMed Kollef MH et al (2019) Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial. Lancet Infect Dis 19(12):1299–1311CrossRefPubMed
32.
Zurück zum Zitat Fachinformation Zerbaxa. 26. Juni 2020. Fachinformation Zerbaxa. 26. Juni 2020.
33.
Zurück zum Zitat Nolan JP et al (2015) European resuscitation council and European Society of Intensive Care Medicine guidelines for post-resuscitation care 2015: section 5 of the European resuscitation council guidelines for resuscitation 2015. Resuscitation 95:202–222CrossRefPubMed Nolan JP et al (2015) European resuscitation council and European Society of Intensive Care Medicine guidelines for post-resuscitation care 2015: section 5 of the European resuscitation council guidelines for resuscitation 2015. Resuscitation 95:202–222CrossRefPubMed
34.
Zurück zum Zitat Lascarrou JB et al (2019) Targeted temperature management for cardiac arrest with nonshockable rhythm. N Engl J Med 381(24):2327–2337CrossRefPubMed Lascarrou JB et al (2019) Targeted temperature management for cardiac arrest with nonshockable rhythm. N Engl J Med 381(24):2327–2337CrossRefPubMed
35.
Zurück zum Zitat PEPTIC Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group et al (2020) Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine‑2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial. JAMA 323(7):616–626 PEPTIC Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group et al (2020) Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine‑2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial. JAMA 323(7):616–626
36.
Zurück zum Zitat Taskforce, D.A.S et al (2015) Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015)—short version. Ger Med Sci 13:Doc19 Taskforce, D.A.S et al (2015) Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015)—short version. Ger Med Sci 13:Doc19
37.
Zurück zum Zitat Olsen HT et al (2020) Nonsedation or light sedation in critically ill, mechanically ventilated patients. N Engl J Med 382(12):1103–1111CrossRefPubMed Olsen HT et al (2020) Nonsedation or light sedation in critically ill, mechanically ventilated patients. N Engl J Med 382(12):1103–1111CrossRefPubMed
38.
Zurück zum Zitat Shehabi Y et al (2019) Early sedation with dexmedetomidine in critically ill patients. N Engl J Med 380(26):2506–2517CrossRefPubMed Shehabi Y et al (2019) Early sedation with dexmedetomidine in critically ill patients. N Engl J Med 380(26):2506–2517CrossRefPubMed
39.
Zurück zum Zitat Jakob SM et al (2012) Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 307(11):1151–1160CrossRefPubMed Jakob SM et al (2012) Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 307(11):1151–1160CrossRefPubMed
40.
Zurück zum Zitat National Heart L et al (2019) Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med 380(21):1997–2008CrossRef National Heart L et al (2019) Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med 380(21):1997–2008CrossRef
41.
Zurück zum Zitat van der Hulle T et al (2017) Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet 390(10091):289–297CrossRefPubMed van der Hulle T et al (2017) Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet 390(10091):289–297CrossRefPubMed
Metadaten
Titel
Fokus allgemeine Intensivmedizin
Intensivmedizinische Studien aus 2019/2020
Publikationsdatum
07.10.2020
Schlagwörter
Sepsis
Sepsis
Erschienen in
Die Anaesthesiologie / Ausgabe 11/2020
Print ISSN: 2731-6858
Elektronische ISSN: 2731-6866
DOI
https://doi.org/10.1007/s00101-020-00857-9

Weitere Artikel der Ausgabe 11/2020

Die Anaesthesiologie 11/2020 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.